| Product Code: ETC9627339 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Pharmacogenetic Testing Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Taiwan Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Taiwan Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Taiwan Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Taiwan Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Taiwan Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Taiwan Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Taiwan Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Taiwan Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among the population about personalized medicine and its benefits |
4.2.2 Growing demand for precision medicine to improve treatment outcomes |
4.2.3 Supportive government initiatives and policies promoting the adoption of pharmacogenetic testing |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenetic testing procedures |
4.3.2 Limited reimbursement policies for pharmacogenetic testing in Taiwan |
4.3.3 Lack of trained healthcare professionals to interpret and implement pharmacogenetic test results effectively |
5 Taiwan Pharmacogenetic Testing Market Trends |
6 Taiwan Pharmacogenetic Testing Market, By Types |
6.1 Taiwan Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Taiwan Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Taiwan Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Taiwan Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Taiwan Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Taiwan Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Taiwan Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Taiwan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Taiwan Pharmacogenetic Testing Market Export to Major Countries |
7.2 Taiwan Pharmacogenetic Testing Market Imports from Major Countries |
8 Taiwan Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of research studies and publications on pharmacogenetics in Taiwan |
8.3 Rate of integration of pharmacogenetic testing into clinical practice |
9 Taiwan Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Taiwan Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Taiwan Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Taiwan Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Taiwan Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Taiwan Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Taiwan Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Taiwan Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Taiwan Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here